These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1718588)

  • 21. Enhanced antitumor activity in mice after administration of thermosensitive liposome encapsulating cisplatin with hyperthermia.
    Iga K; Hamaguchi N; Igari Y; Ogawa Y; Gotoh K; Ootsu K; Toguchi H; Shimamoto T
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1203-7. PubMed ID: 2046024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of hyperthermia in regional alkylating agent chemotherapy.
    Abdel-Wahab OI; Grubbs E; Viglianti BL; Cheng TY; Ueno T; Ko S; Rabbani Z; Curtis S; Pruitt SK; Dewhirst MW; Tyler DS
    Clin Cancer Res; 2004 Sep; 10(17):5919-29. PubMed ID: 15355925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flavone acetic acid increases the cytotoxicity of mitomycin C when combined with hyperthermia.
    Takeuchi H; Baba H; Maehara Y; Sugimachi K; Newman RA
    Cancer Chemother Pharmacol; 1996; 38(1):1-8. PubMed ID: 8603441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Combination therapy of a new platinum complex, DWA2114R with various antitumor agents against mouse tumors in vivo].
    Akamatsu K; Endo K; Tsunenari T; Matsumoto T; Kaiho S; Morikawa K; Koizumi M; Mitsui H; Koizumi K
    Gan To Kagaku Ryoho; 1992 Feb; 19(2):229-35. PubMed ID: 1736835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response of mammary tumors of C3H/He mice to hyperthermia and bleomycin in vivo.
    Ma F; Hiraoka M; Jo S; Akuta K; Nishimura Y; Takahashi M; Abe M
    Radiat Med; 1985; 3(4):230-3. PubMed ID: 2425397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced therapeutic efficacy of cisplatin by combination with diethyldithiocarbamate and hyperthermia in a mouse model.
    Murthy MS; Rao LN; Khandekar JD; Scanlon EF
    Cancer Res; 1987 Feb; 47(3):774-9. PubMed ID: 3026616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Addition of mitomycin C to cis-diamminedichloroplatinum(II)/hyperthermia/radiation therapy in the FSaIIC fibrosarcoma.
    Herman TS; Teicher BA; Holden SA
    Int J Hyperthermia; 1991; 7(6):893-903. PubMed ID: 1806643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergism between alkylating agent and cis-platin with moderate local hyperthermia: the effect of multidrug chemotherapy in an animal system.
    Matsushita S; Reynolds R; Urano M
    Int J Hyperthermia; 1993; 9(2):285-96. PubMed ID: 8468510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
    Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R
    Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-tumor activity of recombinant tumor necrosis factor on mouse fibrosarcoma in vivo and in vitro.
    Tomazic VJ; Farha M; Loftus A; Elias EG
    J Immunol; 1988 Jun; 140(11):4056-61. PubMed ID: 3372997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of 5-hydroxytryptamine on the combination effect of lonidamine or gossypol and hyperthermia on Ehrlich tumour in vivo.
    Molla MR; Yoshiga K; Takada K
    Anticancer Res; 1987; 7(3 Pt B):361-4. PubMed ID: 3631888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
    Teicher BA; Herman TS; Tanaka J; Eder JP; Holden SA; Bubley G; Coleman CN; Frei E
    Cancer Res; 1991 Feb; 51(4):1086-91. PubMed ID: 1825474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined modality clinical trials for favorable B-cell neoplasms: lonidamine plus whole body hyperthermia and/or total body irradiation.
    Robins HI
    Semin Oncol; 1991 Apr; 18(2 Suppl 4):23-7. PubMed ID: 2031194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of hyperthermia on the action of cis-diamminedichloroplatinum(II), rhodamine 123(2) [tetrachloroplatinum(II)], rhodamine 123, and potassium tetrachloroplatinate in vitro and in vivo.
    Herman TS; Teicher BA; Chan V; Collins LS; Kaufmann ME; Loh C
    Cancer Res; 1988 May; 48(9):2335-41. PubMed ID: 3356001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The synergistic effect of human recombinant TNF in combination with various anti-cancer drugs].
    Yamauchi N; Watanabe N; Ohtsuka Y; Sone H; Neda H; Maeda M; Niitsu Y; Urushizaki I
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2730-4. PubMed ID: 3631972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of treatment sequence on efficacy of fluorouracil and cisplatin intratumoral drug delivery in vivo.
    Yu NY; Patawaran MB; Chen JY; Orenberg EK; Brown DM; Luck EE
    Cancer J Sci Am; 1995; 1(3):215-21. PubMed ID: 9166479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluosol-DA/carbogen with lonidamine or pentoxifylline as modulators of alkylating agents in the FSaIIC fibrosarcoma.
    Teicher BA; Herman TS; Tanaka J; Dezube B; Pardee A; Frei E
    Cancer Chemother Pharmacol; 1991; 28(1):45-50. PubMed ID: 1904012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response of S 180 murine tumor to bleomycin in combination with radiation and hyperthermia using micronucleus assay: a multimodality approach for therapeutic augmentation.
    Rao BS; Devi PU
    Indian J Exp Biol; 2005 Jul; 43(7):596-600. PubMed ID: 16053264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potentiation of radiation effects on two murine tumors by lonidamine.
    Kim JH; Alfieri AA; Kim SH; Young CW
    Cancer Res; 1986 Mar; 46(3):1120-3. PubMed ID: 3943089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
    Elliott WL; Roberts BJ; Howard CT; Leopold WR
    Cancer Res; 1994 Aug; 54(16):4412-8. PubMed ID: 8044790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.